Fabricant: FDA Focusing on NDIs, GMPs

<p>FDA's attention on&nbsp;good manufacturing practices, new dietary ingredients and&nbsp;claims isn't letting up, according to Daniel Fabricant, Ph.D., CEO of the Natural Products Association.</p>

FDA's intense focus on good manufacturing practices (GMPs), new dietary ingredients (NDIs) and disease claims is here to stay, according to Daniel Fabricant, Ph.D., CEO of the Natural Products Association (NPA). Fabricant discussed the agency's recent initiatives in his featured presentation Ingredient Marketplace, held on June 2 and 3 in New York City.

This INSIDER News Desk breaks down Fabricant's discussion highlights, including how facility location affects FDA inspections, current NDI statistics and red flag words for disease claims.

For watch Fabricant's presentation in full, register for NPA's webinar "There and Back Again" on June 25.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish